Published in Cancer Res on August 15, 2013
Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers. Gastroenterology (2015) 1.24
MicroRNA-153 acts as a prognostic marker in gastric cancer and its role in cell migration and invasion. Onco Targets Ther (2015) 0.95
MicroRNAs potential utility in colon cancer: Early detection, prognosis, and chemosensitivity. World J Gastroenterol (2015) 0.92
miRNA-99b-5p suppresses liver metastasis of colorectal cancer by down-regulating mTOR. Oncotarget (2015) 0.87
An update on microRNAs as colorectal cancer biomarkers: where are we and what's next? Expert Rev Mol Diagn (2014) 0.87
Stratifying risk of recurrence in stage II colorectal cancer using deregulated stromal and epithelial microRNAs. Oncotarget (2015) 0.86
microRNA expression pattern modulates temozolomide response in GBM tumors with cancer stem cells. Cell Mol Neurobiol (2014) 0.86
MicroRNA-153 promotes Wnt/β-catenin activation in hepatocellular carcinoma through suppression of WWOX. Oncotarget (2015) 0.85
MicroRNA-153 inhibits osteosarcoma cells proliferation and invasion by targeting TGF-β2. PLoS One (2015) 0.84
MicroRNA-217 functions as a prognosis predictor and inhibits colorectal cancer cell proliferation and invasion via an AEG-1 dependent mechanism. BMC Cancer (2015) 0.84
MicroRNA-153 is a prognostic marker and inhibits cell migration and invasion by targeting SNAI1 in human pancreatic ductal adenocarcinoma. Oncol Rep (2015) 0.82
MicroRNA-184 Modulates Doxorubicin Resistance in Osteosarcoma Cells by Targeting BCL2L1. Med Sci Monit (2016) 0.82
MicroRNA-224 promotes the sensitivity of osteosarcoma cells to cisplatin by targeting Rac1. J Cell Mol Med (2016) 0.81
MicroRNAs in the Neural Retina. Int J Genomics (2014) 0.80
MiR-625-3p promotes cell migration and invasion via inhibition of SCAI in colorectal carcinoma cells. Oncotarget (2015) 0.80
miR-19-Mediated Inhibition of Transglutaminase-2 Leads to Enhanced Invasion and Metastasis in Colorectal Cancer. Mol Cancer Res (2015) 0.79
Olea europaea leaf extract improves the treatment response of GBM stem cells by modulating miRNA expression. Am J Cancer Res (2014) 0.79
An update on miRNAs as biological and clinical determinants in colorectal cancer: a bench-to-bedside approach. Future Oncol (2015) 0.79
Down but Not Out: The Role of MicroRNAs in Hibernating Bats. PLoS One (2015) 0.78
Long noncoding RNA CRNDE functions as a competing endogenous RNA to promote metastasis and oxaliplatin resistance by sponging miR-136 in colorectal cancer. Onco Targets Ther (2017) 0.78
The transcribed-ultraconserved regions in prostate and gastric cancer: DNA hypermethylation and microRNA-associated regulation. Oncogene (2015) 0.77
Downregulation of miR-199b is associated with distant metastasis in colorectal cancer via activation of SIRT1 and inhibition of CREB/KISS1 signaling. Oncotarget (2016) 0.76
MicroRNA-153 inhibits the proliferation and invasion of human laryngeal squamous cell carcinoma by targeting KLF5. Exp Ther Med (2016) 0.75
MicroRNAs as regulators and mediators of forkhead box transcription factors function in human cancers. Oncotarget (2017) 0.75
LncRNAs: the bridge linking RNA and colorectal cancer. Oncotarget (2016) 0.75
MicroRNA-93-5p increases multidrug resistance in human colorectal carcinoma cells by downregulating cyclin dependent kinase inhibitor 1A gene expression. Oncol Lett (2016) 0.75
MicroRNA-153 expression and prognosis in non-small cell lung cancer. Int J Clin Exp Pathol (2015) 0.75
miR-153-3p, a new bio-target, is involved in the pathogenesis of acute graft-versus-host disease via inhibition of indoleamine- 2,3-dioxygenase. Oncotarget (2016) 0.75
Molecular profiling of the invasive tumor microenvironment in a 3-dimensional model of colorectal cancer cells and ex vivo fibroblasts. J Vis Exp (2014) 0.75
Non-Coding RNAs as Predictive Biomarkers to Current Treatment in Metastatic Colorectal Cancer. Int J Mol Sci (2017) 0.75
TUSC7 acts as a tumor suppressor in colorectal cancer. Am J Transl Res (2017) 0.75
An integrated expression atlas of miRNAs and their promoters in human and mouse. Nat Biotechnol (2017) 0.75
MicroRNAs: target recognition and regulatory functions. Cell (2009) 92.17
Most mammalian mRNAs are conserved targets of microRNAs. Genome Res (2008) 37.16
Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A (2004) 28.29
Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature (2007) 21.53
Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med (2010) 15.71
Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation. Genome Biol (2004) 15.15
Matrix metalloproteinases: regulators of the tumor microenvironment. Cell (2010) 12.90
The resurgence of platinum-based cancer chemotherapy. Nat Rev Cancer (2007) 12.38
MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA (2008) 12.26
MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene (2007) 10.79
Retracted A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell (2009) 10.51
FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis. Cell (2007) 8.94
Mammalian SIRT1 represses forkhead transcription factors. Cell (2004) 8.89
Cancer incidence and mortality in Europe, 2004. Ann Oncol (2005) 6.47
MicroRNAs in cancer: small molecules with a huge impact. J Clin Oncol (2009) 5.92
miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. BMC Med (2008) 5.91
Breast cancer metastasis suppressor 1 up-regulates miR-146, which suppresses breast cancer metastasis. Cancer Res (2009) 3.40
The chromosomal instability pathway in colon cancer. Gastroenterology (2010) 2.59
CellMiner: a web-based suite of genomic and pharmacologic tools to explore transcript and drug patterns in the NCI-60 cell line set. Cancer Res (2012) 2.57
mRNA/microRNA gene expression profile in microsatellite unstable colorectal cancer. Mol Cancer (2007) 2.40
Definition of microRNAs that repress expression of the tumor suppressor gene FOXO1 in endometrial cancer. Cancer Res (2009) 2.32
Modulation of mismatch repair and genomic stability by miR-155. Proc Natl Acad Sci U S A (2010) 2.05
Post-transcriptional regulation of alpha-synuclein expression by mir-7 and mir-153. J Biol Chem (2010) 1.94
MicroRNA and drug resistance. Cancer Gene Ther (2010) 1.80
Validation of a model of colon cancer progression. J Pathol (2000) 1.76
Development of a quantitative method to analyse tumour cell invasion in organotypic culture. J Pathol (2005) 1.61
Incidence and patterns of recurrence after resection for cure of colonic cancer in a well defined population. Br J Surg (2006) 1.59
Neoplastic transformation of a human colonic epithelial cell line: in vitro evidence for the adenoma to carcinoma sequence. Cancer Res (1990) 1.57
Prediction of colorectal cancer relapse and survival via tissue RNA levels of matrix metalloproteinase-9. J Clin Oncol (1996) 1.39
Multiple uses of basement membrane-like matrix (BME/Matrigel) in vitro and in vivo with cancer cells. Int J Cancer (2011) 1.29
Hyaluronan facilitates invasion of colon carcinoma cells in vitro via interaction with CD44. Cancer Res (2004) 1.22
13q deletion anatomy and disease progression in patients with chronic lymphocytic leukemia. Leukemia (2010) 1.21
A microRNA-dependent program controls p53-independent survival and chemosensitivity in human and murine squamous cell carcinoma. J Clin Invest (2011) 1.19
FOXO3a mediates the cytotoxic effects of cisplatin in colon cancer cells. Mol Cancer Ther (2008) 1.06
Crosstalk between p53 and FOXO transcription factors. Cell Cycle (2005) 1.06
MMP-9 (gelatinase B) expression is associated with disease-free survival and disease-specific survival in colorectal cancer patients. Cancer Invest (2010) 1.04
Inhibition of phosphorylation of a forkhead transcription factor sensitizes human ovarian cancer cells to cisplatin. Endocrinology (2003) 1.01
Gelatinases of metastatic cell lines of murine colonic carcinoma as detected by substrate-gel electrophoresis. Biochem Biophys Res Commun (1988) 1.01
BIM-mediated AKT phosphorylation is a key modulator of arsenic trioxide-induced apoptosis in cisplatin-sensitive and -resistant ovarian cancer cells. PLoS One (2011) 0.97
microRNAs in colon cancer: a roadmap for discovery. FEBS Lett (2012) 0.95
BRCA1-IRIS overexpression promotes cisplatin resistance in ovarian cancer cells. Cancer Res (2010) 0.95
The involvement of FoxO in cell survival and chemosensitivity mediated by Mirk/Dyrk1B in ovarian cancer. Int J Oncol (2011) 0.95
Are microRNAs located in genomic regions associated with cancer? Br J Cancer (2006) 0.93
Chemoradiotherapy for colorectal cancer. Gut (2005) 0.93
Progression-free survival in ovarian cancer is reflected in epigenetic DNA methylation profiles. Oncology (2011) 0.91
Differential role of Fas/Fas ligand interactions in cytolysis of primary and metastatic colon carcinoma cell lines by human antigen-specific CD8+ CTL. J Immunol (2000) 0.90
Foxo3a expression and acetylation regulate cancer cell growth and sensitivity to cisplatin. Cancer Sci (2010) 0.89
Matrix metalloproteinase 2 and 9 activity in patients with colorectal cancer liver metastasis. Br J Surg (2003) 0.89
In vitro and in vivo sensitization of SW620 metastatic colon cancer cells to CDDP-induced apoptosis by the nitric oxide donor DETANONOate: Involvement of AIF. Nitric Oxide (2008) 0.86
FOXO3a reactivation mediates the synergistic cytotoxic effects of rapamycin and cisplatin in oral squamous cell carcinoma cells. Toxicol Appl Pharmacol (2010) 0.83
The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment. Carcinogenesis (2009) 5.01
Regulators of mitotic arrest and ceramide metabolism are determinants of sensitivity to paclitaxel and other chemotherapeutic drugs. Cancer Cell (2007) 3.89
Interaction between beta-catenin and HIF-1 promotes cellular adaptation to hypoxia. Nat Cell Biol (2007) 3.11
Functional metabolic screen identifies 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 as an important regulator of prostate cancer cell survival. Cancer Discov (2012) 3.03
Identification of cis-acting sites for condensin loading onto budding yeast chromosomes. Genes Dev (2008) 2.87
ROCK and JAK1 signaling cooperate to control actomyosin contractility in tumor cells and stroma. Cancer Cell (2011) 2.77
Effectiveness of appropriately trained nurses in preoperative assessment: randomised controlled equivalence/non-inferiority trial. BMJ (2002) 2.48
c-Jun reprograms Schwann cells of injured nerves to generate a repair cell essential for regeneration. Neuron (2012) 2.45
Squamous cell carcinoma arising in a residual odontogenic cyst: case report. J Oral Maxillofac Surg (2005) 2.31
The cannabinoid delta(9)-tetrahydrocannabinol inhibits RAS-MAPK and PI3K-AKT survival signalling and induces BAD-mediated apoptosis in colorectal cancer cells. Int J Cancer (2007) 2.29
B-cell receptor signaling in chronic lymphocytic leukemia. Blood (2011) 2.11
Mcl-1. Int J Biochem Cell Biol (2005) 1.96
Hematopoietic stem cells express multiple myeloid markers: implications for the origin and targeted therapy of acute myeloid leukemia. Blood (2005) 1.93
Combined functional genomic and proteomic approaches identify a PP2A complex as a negative regulator of Hippo signaling. Mol Cell (2010) 1.85
Differential signaling via surface IgM is associated with VH gene mutational status and CD38 expression in chronic lymphocytic leukemia. Blood (2002) 1.85
Type I collagen promotes the malignant phenotype of pancreatic ductal adenocarcinoma. Clin Cancer Res (2004) 1.83
Clinicopathological parameters, recurrence, locoregional and distant metastasis in 115 T1-T2 oral squamous cell carcinoma patients. Head Neck Oncol (2010) 1.81
Imaging macrophage chemotaxis in vivo: studies of microtubule function in zebrafish wound inflammation. Cell Motil Cytoskeleton (2006) 1.79
Antibody-mediated blockade of integrin alpha v beta 6 inhibits tumor progression in vivo by a transforming growth factor-beta-regulated mechanism. Cancer Res (2008) 1.73
An NGF-responsive element targets myo-inositol monophosphatase-1 mRNA to sympathetic neuron axons. Nat Neurosci (2010) 1.68
Deficits in axonal transport precede ALS symptoms in vivo. Proc Natl Acad Sci U S A (2010) 1.66
Targeting B-cell anergy in chronic lymphocytic leukemia. Blood (2013) 1.66
Direct transcriptional up-regulation of cyclooxygenase-2 by hypoxia-inducible factor (HIF)-1 promotes colorectal tumor cell survival and enhances HIF-1 transcriptional activity during hypoxia. Cancer Res (2006) 1.64
Reversible anergy of sIgM-mediated signaling in the two subsets of CLL defined by VH-gene mutational status. Blood (2007) 1.55
Stromal features are predictive of disease mortality in oral cancer patients. J Pathol (2011) 1.54
Mcl-1 is required for Akata6 B-lymphoma cell survival and is converted to a cell death molecule by efficient caspase-mediated cleavage. Oncogene (2004) 1.53
OncoSurge: a strategy for improving resectability with curative intent in metastatic colorectal cancer. J Clin Oncol (2005) 1.52
Increased EP4 receptor expression in colorectal cancer progression promotes cell growth and anchorage independence. Cancer Res (2006) 1.43
Determination of synthetic lethal interactions in KRAS oncogene-dependent cancer cells reveals novel therapeutic targeting strategies. Cell Res (2012) 1.41
MicroRNAs: critical regulators of epithelial to mesenchymal (EMT) and mesenchymal to epithelial transition (MET) in cancer progression. Biol Cell (2011) 1.41
Hedgehog signalling in colorectal tumour cells: induction of apoptosis with cyclopamine treatment. Int J Cancer (2004) 1.41
The NF-kappaB p50:p50:HDAC-1 repressor complex orchestrates transcriptional inhibition of multiple pro-inflammatory genes. J Hepatol (2010) 1.37
S-adenosylhomocysteine hydrolase inhibition by 3-deazaneplanocin A analogues induces anti-cancer effects in breast cancer cell lines and synergy with both histone deacetylase and HER2 inhibition. Breast Cancer Res Treat (2010) 1.36
HS1-associated protein X-1 regulates carcinoma cell migration and invasion via clathrin-mediated endocytosis of integrin alphavbeta6. Cancer Res (2007) 1.33
Mediators of PGE2 synthesis and signalling downstream of COX-2 represent potential targets for the prevention/treatment of colorectal cancer. Biochim Biophys Acta (2006) 1.33
Expression of HIF-1alpha, HIF-2alpha (EPAS1), and their target genes in paraganglioma and pheochromocytoma with VHL and SDH mutations. J Clin Endocrinol Metab (2006) 1.31
BAG-1: a multifunctional regulator of cell growth and survival. Biochim Biophys Acta (2003) 1.26
Budding yeast Wapl controls sister chromatid cohesion maintenance and chromosome condensation. Curr Biol (2012) 1.24
Condensin-dependent rDNA decatenation introduces a temporal pattern to chromosome segregation. Curr Biol (2008) 1.23
Farnesoid x receptor ligands inhibit vascular smooth muscle cell inflammation and migration. Arterioscler Thromb Vasc Biol (2007) 1.22
HIF-2α protects human hematopoietic stem/progenitors and acute myeloid leukemic cells from apoptosis induced by endoplasmic reticulum stress. Cell Stem Cell (2013) 1.18
Genes involved in differentiation, stem cell renewal, and tumorigenesis are modulated in telomerase-immortalized human urothelial cells. Mol Cancer Res (2008) 1.18
Human colorectal adenomas demonstrate a size-dependent increase in epithelial cyclooxygenase-2 expression. J Pathol (2002) 1.17
Nitric oxide is a factor in the stabilization of hypoxia-inducible factor-1alpha in cancer: role of free radical formation. Cancer Res (2006) 1.17
The normal IGHV1-69-derived B-cell repertoire contains stereotypic patterns characteristic of unmutated CLL. Blood (2009) 1.15
BAG-1: a multi-functional pro-survival molecule. Int J Biochem Cell Biol (2005) 1.14
Glycosylation of surface Ig creates a functional bridge between human follicular lymphoma and microenvironmental lectins. Proc Natl Acad Sci U S A (2010) 1.14
Genome-wide RNA interference analysis of renal carcinoma survival regulators identifies MCT4 as a Warburg effect metabolic target. J Pathol (2012) 1.14
Increased angiogenic sprouting in poor prognosis FL is associated with elevated numbers of CD163+ macrophages within the immediate sprouting microenvironment. Blood (2010) 1.12
Surface IgM stimulation induces MEK1/2-dependent MYC expression in chronic lymphocytic leukemia cells. Blood (2011) 1.11
Total synthesis of spiruchostatin A, a potent histone deacetylase inhibitor. J Am Chem Soc (2004) 1.11
alpha vbeta 6 Integrin promotes the invasion of morphoeic basal cell carcinoma through stromal modulation. Cancer Res (2008) 1.11
A novel single nucleotide polymorphism in the 3' untranslated region of human glutathione peroxidase 4 influences lipoxygenase metabolism. Blood Cells Mol Dis (2002) 1.09
Mechanisms and clinical significance of BIM phosphorylation in chronic lymphocytic leukemia. Blood (2011) 1.09
The first biologically active synthetic analogues of FK228, the depsipeptide histone deacetylase inhibitor. J Med Chem (2007) 1.09
The desmoplastic reaction surrounding hepatic colorectal adenocarcinoma metastases aids tumor growth and survival via alphav integrin ligation. Clin Cancer Res (2008) 1.08
Altered microenvironment promotes progression of preinvasive breast cancer: myoepithelial expression of αvβ6 integrin in DCIS identifies high-risk patients and predicts recurrence. Clin Cancer Res (2013) 1.06
Cancer-associated fibroblasts predict poor outcome and promote periostin-dependent invasion in oesophageal adenocarcinoma. J Pathol (2015) 1.06
Identification in CLL of circulating intraclonal subgroups with varying B-cell receptor expression and function. Blood (2013) 1.05
The MEK/ERK pathway mediates COX-2-selective NSAID-induced apoptosis and induced COX-2 protein expression in colorectal carcinoma cells. Int J Cancer (2002) 1.04
HGF/Met signalling promotes PGE(2) biogenesis via regulation of COX-2 and 15-PGDH expression in colorectal cancer cells. Carcinogenesis (2009) 1.04
The nuclear BAG-1 isoform, BAG-1L, enhances oestrogen-dependent transcription. Oncogene (2003) 1.04
Myofibroblastic differentiation leads to hyaluronan accumulation through reduced hyaluronan turnover. J Biol Chem (2004) 1.03
MicroRNA Control of Invasion and Metastasis Pathways. Front Genet (2011) 1.02
Colon tumour cells increase PGE(2) by regulating COX-2 and 15-PGDH to promote survival during the microenvironmental stress of glucose deprivation. Carcinogenesis (2011) 1.02
BAG-1 prevents stress-induced long-term growth inhibition in breast cancer cells via a chaperone-dependent pathway. Cancer Res (2003) 1.01
Prostaglandin F(2alpha) stimulates motility and invasion in colorectal tumor cells. Int J Cancer (2007) 1.00
Inhibition of hypoxia inducible factor by phenethyl isothiocyanate. Biochem Pharmacol (2009) 1.00
Betel-derived alkaloid up-regulates keratinocyte alphavbeta6 integrin expression and promotes oral submucous fibrosis. J Pathol (2010) 1.00
Extracellular growth factors and mitogens cooperate to drive mitochondrial biogenesis. J Cell Sci (2009) 0.99
Increased nitric oxide levels as an early sign of premature aging in diabetes. Free Radic Biol Med (2003) 0.99
Comparative analysis of PCR-based biomarker assay methods for colorectal polyp detection from fecal DNA. Clin Chem (2009) 0.98
Enantioselective synthesis of tranylcypromine analogues as lysine demethylase (LSD1) inhibitors. Bioorg Med Chem (2011) 0.97
BAG-1 is up-regulated in colorectal tumour progression and promotes colorectal tumour cell survival through increased NF-kappaB activity. Carcinogenesis (2008) 0.96
Changes in brain activation to food pictures after adjustable gastric banding. Surg Obes Relat Dis (2011) 0.96
A kinesin-1 binding motif in vaccinia virus that is widespread throughout the human genome. EMBO J (2011) 0.96
Cyclooxygenase-2 inhibition suppresses alphavbeta6 integrin-dependent oral squamous carcinoma invasion. Cancer Res (2006) 0.95
Predicting colorectal cancer risk in patients with rectal bleeding. Br J Gen Pract (2006) 0.95
Progression of genotype-specific oral cancer leads to senescence of cancer-associated fibroblasts and is mediated by oxidative stress and TGF-β. Carcinogenesis (2013) 0.95
BAG-1 proteins protect cardiac myocytes from simulated ischemia/reperfusion-induced apoptosis via an alternate mechanism of cell survival independent of the proteasome. J Biol Chem (2004) 0.94
Characterisation of the in vitro activity of the depsipeptide histone deacetylase inhibitor spiruchostatin A. Biochem Pharmacol (2008) 0.94
Prospective randomized clinical trial of the effect of needle size on pain, sample adequacy and accuracy in head and neck fine-needle aspiration cytology. Head Neck (2007) 0.94
The endogenous cannabinoid, anandamide, induces COX-2-dependent cell death in apoptosis-resistant colon cancer cells. Int J Oncol (2010) 0.94
Total synthesis of largazole and analogues: HDAC inhibition, antiproliferative activity and metabolic stability. Bioorg Med Chem (2011) 0.93
An rtt109-independent role for vps75 in transcription-associated nucleosome dynamics. Mol Cell Biol (2009) 0.93
O-glycan inhibitors generate aryl-glycans, induce apoptosis and lead to growth inhibition in colorectal cancer cell lines. Glycobiology (2009) 0.93
Tumor-stromal interactions in pancreatic cancer. Pancreatology (2012) 0.92
Current strategies to target the anti-apoptotic Bcl-2 protein in cancer cells. Curr Med Chem (2004) 0.92
Differential expression proteomics of human colorectal cancer based on a syngeneic cellular model for the progression of adenoma to carcinoma. Proteomics (2010) 0.92
BAG-1 in carcinogenesis. Expert Rev Mol Med (2004) 0.92
Surface IgM of CLL cells displays unusual glycans indicative of engagement of antigen in vivo. Blood (2010) 0.91
The transcriptional coactivator p300 plays a critical role in the hypertrophic and protective pathways induced by phenylephrine in cardiac cells but is specific to the hypertrophic effect of urocortin. Chembiochem (2005) 0.91
Proteomic analysis of archival breast cancer serum. Cancer Genomics Proteomics (2009) 0.91
Regulation of lymphatic-blood vessel separation by endothelial Rac1. Development (2009) 0.91
Stable XIAP knockdown clones of HCT116 colon cancer cells are more sensitive to TRAIL, taxanes and irradiation in vitro. Cancer Chemother Pharmacol (2008) 0.90